Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic pain
US-2025319092-A1 · Oct 16, 2025 · US
Goldberg Michael E is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Goldberg Michael E |
| Total patents | 6 |
| First publication | Feb 23, 2017 |
| Latest publication | Oct 16, 2025 |
Publications ranked by popularity score, then publication date.
US-2025319092-A1 · Oct 16, 2025 · US
US-2020360393-A1 · Nov 19, 2020 · US
US-2018098993-A1 · Apr 12, 2018 · US
US-9867830-B2 · Jan 16, 2018 · US
US-9650352-B2 · May 16, 2017 · US
US-2017049780-A1 · Feb 23, 2017 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Cooper Health System | 6 |
| Stanford Res Inst Int | 6 |
| Us Health | 4 |
| The Us Secretary Department Of Health And Human Servic | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 6 |
| A61K31/135 | 6 |
| C07D295/15 | 6 |
| A61P25/18 | 6 |
| C07C2601/16 | 6 |